Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer ’s disease and down syndrome

This study is aimed to determine whether quantification of pl...

Source: Molecular Neurodegeneration - September 4, 2017 Category: Neurology Authors: Harutsugu Tatebe, Takashi Kasai, Takuma Ohmichi, Yusuke Kishi, Tomoshi Kakeya, Masaaki Waragai, Masaki Kondo, David Allsop and Takahiko Tokuda Tags: Research article Source Type: research